LIO Pack: Fosun Wei Shi plans to reduce its stake by 3.00%

Lyno Pharmaceutical announced that its shareholder Fosun Weishi, with a total holding of 6.5395% of the shares, and its concerted actor Fosun Weiyin Plan, plan to reduce their holdings through centralized competitive bidding by no more than 2.3262 million shares, representing 1.0000% of the total share capital, and through block trading by no more than 4.6525 million shares, representing 2.0000% of the total share capital, for a total of no more than 6.9787 million shares, accounting for 3.0000% of the total share capital. Former director Xu Guangcheng plans to reduce his holdings by no more than 1.4286 million shares, representing 0.6141% of the total share capital during the same period.